Booming Pharma Sector in India

Table of Contents

1. Analyst View

2. Global Pharmaceutical Market

3. India - The Emerging Market

4. India - Macroeconomic & Healthcare Profile

• 4.1 Macroeconomic Profile
• 4.2 Population Profile
• 4.3 Healthcare Profile

5. Indian Pharmaceutical Market

• 5.1 Turnover
• 5.2 Trade
  • 5.2.1 Export
  • 5.2.2 Import
• 5.3 Bulk Drugs & Formulations

6. Domestic Pharmaceutical Market

• 6.1 What Makes the Market so Lucrative?
  • 6.1.1 Ageing Population
  • 6.1.2 Increasing Income
  • 6.1.3 Product Patent Regime
  • 6.1.4 Medical Infrastructure
  • 6.1.5 Prevalence of Lifestyle-related Diseases
• 6.2 Market Size
• 6.3 Market Segmentation
  • 6.3.1 By Drugs
    • 6.3.1.1 Traditional Branded Generics
    • 6.3.1.2 Specialty Branded Generics
    • 6.3.1.3 Generic Generics
    • 6.3.1.4 Patented Drugs
  • 6.3.2 By Therapeutics
    • 6.3.2.1 Acute Segment
      • 6.3.2.1.1 Anti-infectives
      • 6.3.2.1.2 Gastrointestinal
      • 6.3.2.1.3 Vitamins/Minerals/Nutrients
      • 6.3.2.1.4 Pain/Analgesics
      • 6.3.2.1.5 Dermatology
      • 6.3.2.1.6 Gynecology
      • 6.3.2.1.7 Respiratory
    • 6.3.2.2 Chronic Segment
      • 6.3.2.2.1 Cardiac
      • 6.3.2.2.2 Neuro/CNS
      • 6.3.2.2.3 Anti-diabetic
• 6.4 Market Structure
• 6.5 Key Players
• 6.6 Future Outlook
  • 6.6.1 Market Drivers & Restraints
  • 6.6.2 Sales (2008-09 to 2011-12)

7. Government Regulations & Market Entry

• 7.1 Industrial & Manufacturing License
• 7.2 Patent Laws
• 7.3 Research & Development
• 7.4 Pricing
• 7.5 Market Entry

8. Opportunities

• 8.1 Biogenerics
• 8.2 Rural Markets
• 8.3 Pharma Outsourcing Market
• 8.4 Bioinformatics
• 8.5 Health Insurance
• 8.6 Drug Delivery & Packaging Industry
• 8.7 Pharmaceutical Retail Chains

9. Roadblocks

• 9.1 Lack of Innovation
• 9.2 Drug Price Controls & Low Margins
• 9.3 Low Per Capita Spending on Drugs
• 9.4 Multinationals Reluctant to Invest in India
• 9.5 Counterfeit Drugs
• 9.6 Government Financing

10. Profile of Key Players

• 10.1 Ranbaxy Laboratories Limited
• 10.2 Cipla Limited
• 10.3 GlaxoSmithKline Pharmaceuticals Limited
• 10.4 Nicholas Piramal India Limited
• 10.5 Zydus Cadila

List of Figures:

• Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 2002, 2006, 2007 & 2012F
• Figure 3-1: Global - Top Pharmaceutical Markets (in Billion US$), 2005
• Figure 3-2: Global - Forecast for Top Pharmaceutical Markets (in Billion US$), 2015
• Figure 3-3: Global - CAGR of Top Pharmaceutical Markets (%), 2005 to 2015
• Figure 4-1: India - Nominal GDP (in Billion US$), 2001-2007
• Figure 4-2: India - Forecast for Nominal GDP (in Billion US$) 2008*-2011
• Figure 4-3: India - Consumer Price Index (%), 2001-2007
• Figure 4-4: India - Forecast for Consumer Price Index (%), 2008*-2011
• Figure 4-5: India - Total FDI (in Billion US$), 2002-03 to 2007-08
• Figure 4-6: India - FDI in Pharmaceutical Sector (in Million US$), 2003-04 to 2006-07
• Figure 4-7: India - Population (in Billion), 2003-2007
• Figure 4-8: India - Forecast for Population (in Billion), 2008*-2011
• Figure 4-9: India - Population by Gender (%), 2003-2006
• Figure 4-10: India - Population Breakup by Age (%), 2003-2007
• Figure 4-11: India - Forecast for Population Breakup by Age (%), 2008*-2011
• Figure 4-12: India - Per Head Healthcare Spending (in US$), 2001-2007
• Figure 4-13: India - Forecast for Per Head Healthcare Spending (in US$), 2008*-2011
• Figure 4-14: India - Healthcare Payments by Source (%), 2006
• Figure 4-15: India - Number of Doctors (in ' 000) 2005-2007E
• Figure 4-16: India - Forecast for Number of Doctors (in ' 000), 2008-2011
• Figure 4-17: India - Number of Nurses (in ' 000), 2004-2007E
• Figure 4-18: India - Forecast for Number of Nurses (in ' 000), 2008-2011
• Figure 4-19: India - Number of Hospital Beds (in ' 000), 2004-2007E
• Figure 4-20: India - Forecast for Number of Hospital Beds (in ' 000), 2008-2011
• Figure 4-21: India - Number of Deaths due to Leading Causes (in ' 000), 2005
• Figure 4-22: India - Leading Causes of Death (%), 2005
• Figure 4-23: India - Forecast for Leading Causes of Death (%), 2030
• Figure 5-1: India - Pharmaceutical Market Turnover* (in Billion INR), 2001-02 to 2007-08
• Figure 5-2: India - Breakup of Pharmaceutical Market (%), 2007-08
• Figure 5-3: India - Pharmaceutical Exports (in Billion INR), 2000-01 to 2007-08
• Figure 5-4: India - Major API Exports (in Billion INR), 2005-06
• Figure 5-5: India - Major Dosage Form Exports (in Billion INR), 2005-06
• Figure 5-6: India - Pharmaceutical Exports by Region (%), 2005-06
• Figure 5-7: India - Forecast for Pharmaceutical Exports (in Billion INR), 2008-09 to 2011-12
• Figure 5-8: India - Pharmaceutical Imports (in Billion INR), 2000-01 to 2007-08E
• Figure 5-9: India - Pharmaceutical Imports by Group (%), 2005
• Figure 5-10: India - Bulk Drugs Production* (in Billion INR), 2001-02 to 2007-08E
• Figure 5-11: India - Formulations Production* (in Billion INR), 2001-02 to 2007-08E
• Figure 6-1: India - Population of People above 65 Years (in Million), 2003-2007E
• Figure 6-2: India - Income Distribution among Households (%), 1989-90, 2001-02 & 2006-07E
• Figure 6-3: India - Prevalence of Lifestyle-related Diseases (%), 2005
• Figure 6-4: India - Share of Mass & Specialty Therapies in Pharmaceutical Market (%), 2004, 2006 & 2015F
• Figure 6-5: India - Domestic Pharmaceutical Market* (in Billion INR), 2001-02 to 2007-08
• Figure 6-6: India - Domestic Pharmaceutical Market by Drug Category (%), 2004
• Figure 6-7: India - Forecast for Domestic Pharmaceutical Market by Drug Category (%), 2010
• Figure 6-8: India - Traditional Branded Generics Market (in Billion US$), 2004 & 2010F
• Figure 6-9: India - Specialty Branded Generics Market (in Billion US$), 2004 & 2010F
• Figure 6-10: India - Generic Generics Market (in Billion US$), 2004 & 2010F
• Figure 6-11: India - Patented Drugs Market (in Billion US$), 2004 & 2010F
• Figure 6-12: India - Domestic Pharmaceutical Market by Therapeutic Category (%), 2007
• Figure 6-13: India - CAGR Growth of Major Therapeutic Categories (%), 2007 to 2011
• Figure 6-14: India - Anti-infectives Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-15: India - Gastrointestinal Drugs Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-16: India - Vitamins/Minerals/Nutrients Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-17: India - Pain/Analgesics Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-18: India - Dermatology Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-19: India - Gynecology Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-20: India - Number of Asthma Patients (in Million), 2005 & 2015F
• Figure 6-21: India - Respiratory Drugs Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-22: India - Number of Coronary Heart Patients (in Million), 2005 & 2015F
• Figure 6-23: India - Cardiac Drugs Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-24: India - Neuro/CNS Drugs Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-25: India - Number of Diabetes Patients (in Million), 2005 & 2015F
• Figure 6-26: India - Diabetes Market (in Billion INR), 2006, 2007 & 2011F
• Figure 6-27: India - Share of Companies in Pharmaceutical Market (%), 2006
• Figure 6-28: India - Income Distribution among Households (%), 2006-07* & 2011-12F
• Figure 6-29: India - Forecast for Prevalence of Lifestyle-related Diseases (%), 2015
• Figure 6-30: India - Forecast for Population of People above 65 Years (in Million), 2008-2011
• Figure 6-31: India - Forecast for Domestic Pharmaceutical Market* (in Billion INR), 2008-09 to 2011-12
• Figure 8-1: Global - Biogenerics Market (in Million US$), 2006 & 2011F
• Figure 8-2: India - Pharmaceutical Market by Geographical Tier (%), 2005
• Figure 8-3: India - Forecast for Pharmaceutical Market by Geographical Tier (%), 2011
• Figure 8-4: India - Pharma Outsourcing Market (in Million US$), 2004, 2006 & 2007E
• Figure 8-5: India - Pharma Outsourcing Market by Segment (%), 2006
• Figure 8-6: India - Forecast for Pharma Outsourcing Market (in Million US$), 2008-2011
• Figure 8-7: India - Forecast for Pharma Outsourcing Market by Segment (%), 2011
• Figure 8-8: India - Bioinformatics Market (in Million US$), 2002-03 to 2006-07 & 2011-12F
• Figure 8-9: India - Health Insurance Market (in Billion INR), 2001-02, 2006-07 & 2011-12F
• Figure 8-10: India - Drug Packaging Market (in Billion INR), 2006-07* & 2011-12F
• Figure 9-1: India & Global - Proportion of Revenue Spent on R&D (%), 2005
• Figure 9-2: India - Spending on R&D (in Million US$), 2000-01 to 2005-06
• Figure 9-3: Global - Per Capita Drug Consumption in Top Pharmaceutical Markets (in US$), 2006
• Figure 9-4: Global - Share of State & Personal Financing in Top Pharmaceutical Markets (%), 2006

List of Tables:

• Table 2-1: Global - Market Share & Growth of Leading Therapy Classes (%), 2006
• Table 2-2: Global - Pharmaceutical Market by Region (in Billion US$), 2007
• Table 5-1: India - Pharmaceutical Exports to Top Countries (in Million US$), 2003-2005
• Table 5-2: India - Pharmaceutical Imports from Top Countries (in Million US$), 2003-2005
• Table 6-1: India - Top 20 Pharmaceutical Companies by Retail Sales (in Million INR), 2006
• Table 6-2: India - Top 20 Pharmaceutical Companies by Retail Sales (in Million INR), 2007
• Table 7-1: India - Launch of Patented Drugs by Product & Company
• Table 8-1: India - Number of Drug Delivery Companies by Formulation Type (1999, 2003 & 2007E)
• Table 8-2: India - Expansion Plans of Pharmacy Retail Chains
• Table 9-1: India - Counterfeit Drugs in Domestic Pharmaceutical Market